JPA Health | O'Dwyer's PR Firms Directory
Premier database and directory of PR firms & public relations agencies. Find the firm that best suits your needs.
Source: odwyerpr.com
Stefanie Tuck News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stefanie Tuck. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stefanie Tuck Today - Breaking & Trending Today
PR News | Guiding Clients Through FDA Court Battles
How PR leaders can help life-sciences clients navigate the murky waters of FDA court rulings.
Source: odwyerpr.com
BRG Communications names Edelman, Ogilvy alum Michael Sloan as COO
BRG Communications names Edelman, Ogilvy alum Michael Sloan as COO. From PR Week
Source: prweek.com
Visby Medical's COVID-19 PCR Point of Care Test Authorized for Use in CLIA Waived Settings
Share this article Share this article SAN JOSE, Calif., Feb. 10, 2021 /PRNewswire/ -- Visby Medical™ announced today the US Food and Drug Administration (FDA) authorized Visby's rapid PCR COVID-19 test for use at the point of care (POC). Building on the FDA's emergency use authorization granted earlier this year, Visby Medical's rapid PCR COVID-19 test may now be used by any organization with a Clinical Laboratory Improvement Amendments (CLIA) certificate of waiver. Visby Medical Test - Now Authorized for CLIA-Waived Settings It is imperative that the best tools are available to fight infec...
Source: prnewswire.com
Zogenix's FINTEPLA® (Fenfluramine) Oral Solution Now Available in Germany for the Treatment of Seizures in Dravet Syndrome
Published: Feb 01, 2021 FINTEPLA offers a new treatment option for patients in Germany with Dravet syndrome, a rare, devastating, infant-onset epilepsy marked by frequent seizures, medical emergencies, and developmental impairments FINTEPLA was approved by the European Commission in December 2020 based on data from two Phase 3 studies demonstrating it safely and significantly reduced convulsive seizure frequency for Dravet syndrome patients whose seizures were not adequately controlled on their existing medications EMERYVILLE, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Zogenix (NASDAQ: ZG...
Source: biospace.com